Open AccessResults of a clinical study of the drug bilobil
Author(s) -
Т. В. Соколова,
M N Dubova,
S. S. Pavlov
Publication year - 2002
Publication title -
nevrologičeskij vestnik
Language(s) - English
Resource type - Journals
eISSN - 2304-3067
pISSN - 1027-4898
DOI - 10.17816/nb89920
Subject(s) - blood circulation , drug , pharmacology , neurotransmission , ginkgo biloba , chemistry , biology , medicine , receptor , biochemistry , traditional medicine
For clinical study, bilobil was presented in the form of dark lilac capsules containing a yellowish powder with a specific odor, bitter in taste, which is an extract of the leaves of the relict tree ginkto biloba, at a dose of 40 mg.The active components of the extract are flavonoids, ginkcolides and bilobalides, which dilate blood vessels, improve blood circulation, metabolism, prevent platelet aggregation, and protect cells and tissues from damage resulting from a lack of oxygen. Bilobil capsules improve blood supply to the brain, metabolism and prevent decreased performance. Acting on neuronal transmission by facilitating the release of monoamines into the synaptic cleft and increasing the density of synaptic receptors, the drug has a beneficial effect on brain structures.